EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urea levels and cardiovascular disease in patients with chronic kidney disease

Solène M Laville iD, Aymeric Couturier, Oriane Lambert, Marie Metzger, Nicolas Mansencal iD, Christian Jacquelinet, Maurice Laville, Luc Frimat, Denis Fouque, Christian Combe iD, Bruce M Robinson, Bénédicte Stengel und 3 weitere

Nephrology Dialysis Transplantation · 23.01.2023 · 38 (1) · 184-192

DOI: 10.1093/ndt/gfac045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 26.02.2022. Verfasst von Solène M Laville und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Amiens University Hospital, Amiens, France. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agence Nationale de la Recherche, GlaxoSmithKline, Otsuka Pharmaceutical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated serum urea levels are common in moderate-to-advanced chronic kidney disease (CKD). Several studies have shown that urea is a direct and indirect uraemic toxin, especially with regard to cardiovascular disease. We sought to determine whether serum urea levels are associated with adverse cardiovascular events and death before renal replacement therapy (RRT) in patients with CKD.

Methods

CKD-REIN is a prospective cohort of CKD nephrology outpatients not receiving maintenance dialysis. The 2507 patients included in the analysis were divided into three groups according to the baseline serum urea level (T1 <10.5, T2 10.5–15.1 and T3 ≥15.1 mmol/L). Cox proportional hazard models were used to estimate hazard ratios (HRs) for first atheromatous or non-atheromatous cardiovascular (CV) events and all-cause mortality before RRT. The models were adjusted for baseline comorbidities, laboratory data and medications.

Findings

Of the 2507 included patients {median [interquartile range (IQR)] age: 69 [61–77]; mean (standard deviation) estimated glomerular filtration rate (eGFR) 33.5 (11.6) mL/min/1.73 m²}, 54% had a history of cardiovascular disease. After multiple adjustments for CV risk factors (including eGFR), patients in T3 had a higher risk of atheromatous and non-atheromatous CV events than patient in T1 (n events = 451, HR [95% CI]: 1.93 [1.39; 2.69]). The adjusted HRs for death before RRT (n events = 407) were 1.31 [0.97; 1.76] and 1.73 [1.22; 2.45] for patients T2 and those in T3, respectively.

Interpretation

Our data suggested that urea is a predictor of CV outcomes beyond CV risk factors including eGFR.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasechronic kidney diseaseureauremic toxin

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Amiens University Hospital, Amiens, France.
  • MP3CV Laboratory, EA7517, University of Picardie Jules Verne, Amiens, France.
  • Department of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, Paris, France.
  • Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Versailles Saint Quentin University, INSERM UMRS, 1018 Villejuif, France.
  • Department of Cardiology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, Paris, France.
  • Biomedecine Agency, Saint Denis La Plaine, France.

ORCID-Profile: Solène M Laville, Nicolas Mansencal, Christian Combe, Sophie Liabeuf

Förderung

  • Agence Nationale de la Recherche
  • GlaxoSmithKline
  • Otsuka Pharmaceutical
  • Baxter
  • Merck Sharp & Dohme
  • AstraZeneca

Zitieren

APA

Laville, S. M., Couturier, A., Lambert, O., Metzger, M., Mansencal, N., Jacquelinet, C., Laville, M., Frimat, L., Fouque, D., Combe, C., Robinson, B. M., Stengel, B., Liabeuf, S., Massy, Z. A., & CKD-REIN study collaborators (2023). Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 38(1), 184-192. https://doi.org/10.1093/ndt/gfac045

Vancouver

Laville SM, Couturier A, Lambert O, Metzger M, Mansencal N, Jacquelinet C, et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 2023;38(1):184-192. doi:10.1093/ndt/gfac045

BibTeX
@article{Laville2023,
  author = {Laville, Solène M and Couturier, Aymeric and Lambert, Oriane and Metzger, Marie and Mansencal, Nicolas and Jacquelinet, Christian and Laville, Maurice and Frimat, Luc and Fouque, Denis and Combe, Christian and Robinson, Bruce M and Stengel, Bénédicte and Liabeuf, Sophie and Massy, Ziad A and CKD-REIN study collaborators, CKD-REIN study collaborators},
  title = {Urea levels and cardiovascular disease in patients with chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {1},
  pages = {184--192},
  doi = {10.1093/ndt/gfac045}
}
Kostenlos starten →